Research continues to combat Parkinson's, which usually affects people later life, over 1 percent of plus 65's having it.
It's attributed to limited dopamine supply to the brain, which can lead to fatal complications.
Japanese researchers said they had successfully treated monkeys with Parkinson's through stem cell transplantation.
Stem cell research was also to begin in Switzerland and South Korea.
British scientists pinpointed a tiny genetic flaw to blame for about 4 percent of cases.
AMGEN pharmaceuticals stopped investigating their drug GDNF, after deciding it was too risky, its success attributed to the placebo effect.
